News

pharmaphorum2d
Moderna gets FDA okay for RSV vaccine mResvia - pharmaphorum
Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.
MedPage Today on MSN4d
RSV Vaccine Tied to Lower Dementia Risk
Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...
Verywell Health on MSN3d
CDC Advisory Panel Endorses Merck’s New RSV Shot for Infants
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
Soy Carmín on MSN4d
Surprising Twist: RFK Jr.'s New Vaccine Panel Recommends RSV Shot for Infants
In a move that has left many public health observers reeling, a newly appointed vaccine committee under Health and Human Services Secretary Robert F. Kennedy Jr. has voted to recommend an RSV shot for ...
Straight Arrow News on MSN4d
CDC's restructured vaccine panel begins childhood immunization review
The CDC's new vaccine panel is reviewing childhood immunization schedule, including dose timing, ingredients and cumulative effects.
BioPharma Dive5d
CDC panel, newly remade by RFK Jr., questions vaccine evidence
New members of the ACIP panel raised questions about the evidence supporting COVID vaccines, and signaled plans to look at ...
pharmaphorum5d
FDA announces generative AI pilot and rapid rollout plans
In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...